Concepedia

Shiyang Sun

SS

Statistics

Publications

6

Citations

230

H-Index

6

Active since

2021

Affiliations

Institute of Pharmacology(Current)

Beijing Proteome Research Center

National Institutes for Food and Drug Control

Shiyang Sun is an author at Institute of Pharmacology specializing in pharmacology, drug discovery, and molecular oncology.

Publications per year

2021–2024

6

Publications

6

Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism

Pengyun Li, Qiaohong Lin, Shiyang Sun et al. · Cell Death and Disease · 2022 · 87 citations · Full text

, , +14

Discovery of highly potent and selective KRASG12C degraders by VHL-recruiting PROTACs for the treatment of tumors with KRASG12C-Mutation

Ning Yang, Zhiya Fan, Shiyang Sun et al. · European Journal of Medicinal Chemistry · 2023 · 36 citations

, , +8

Discovery of highly potent and selective CRBN-recruiting EGFRL858R/T790M degraders in vivo

Wenjuan Zhang, Pengyun Li, Shiyang Sun et al. · European Journal of Medicinal Chemistry · 2022 · 32 citations

, , +6

Discovery of novel exceptionally potent and orally active c-MET PROTACs for the treatment of tumors with MET alterations

Pengyun Li, Changkai Jia, Zhiya Fan et al. · Acta Pharmaceutica Sinica B · 2023 · 27 citations · Full text

, , +13

Discovery of highly potent and selective EGFRT790M/L858R TKIs against NSCLC based on molecular dynamic simulation

Tingting Yang, Wenjuan Zhang, Shengjie Cao et al. · European Journal of Medicinal Chemistry · 2021 · 26 citations · Full text

, , +14

1–5 of 6